119 related articles for article (PubMed ID: 96459)
21. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
Prusoff BA; Williams DH; Weissman MM; Astrachan BM
Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
[TBL] [Abstract][Full Text] [Related]
22. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
[TBL] [Abstract][Full Text] [Related]
23. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
Langer G; Sachar EJ; Halpern FS
Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
[No Abstract] [Full Text] [Related]
24. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
[TBL] [Abstract][Full Text] [Related]
25. Effect of perphenazine enanthate in Pyrenean chamois (Rupicapra pyrenaica).
Marco I; Cabezón O; Mentaberre G; Fernández-Sirera L; Casas-Díaz E; Fernandez-Aguilar X; López-Olvera JR; Serrano E; Navarro-Gonzalez N; Lavín S; Manteca X
J Zoo Wildl Med; 2013 Dec; 44(4):1083-5. PubMed ID: 24450074
[TBL] [Abstract][Full Text] [Related]
26. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C
Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
[TBL] [Abstract][Full Text] [Related]
29. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
[TBL] [Abstract][Full Text] [Related]
30. The effects of perphenazine and bromocriptine on follicular dynamics and endocrine profiles in anestrous pony mares.
Bennett-Wimbush K; Loch WE; Plata-Madrid H; Evans T
Theriogenology; 1998 Mar; 49(4):717-33. PubMed ID: 10732080
[TBL] [Abstract][Full Text] [Related]
31. Pergolide, a potent long-acting dopamine-receptor agonist.
Lemberger L; Crabtree R; Callaghan JT
Clin Pharmacol Ther; 1980 May; 27(5):642-51. PubMed ID: 7189453
[TBL] [Abstract][Full Text] [Related]
32. BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia.
Fitzgerald PB
Curr Opin Investig Drugs; 2010 Jan; 11(1):92-100. PubMed ID: 20047163
[TBL] [Abstract][Full Text] [Related]
33. Serum prolactin level increase in normal subjects following administration of perphenazine oral dosage forms: possible application to bioavailability testing.
Erb RJ; Stoltman WP
J Pharm Sci; 1982 Aug; 71(8):883-8. PubMed ID: 7120089
[TBL] [Abstract][Full Text] [Related]
34. The effect of phenothiazine on plasma prolactin levels in non-pregnant mares.
Loch W; Worthy K; Ireland F
Equine Vet J; 1990 Jan; 22(1):30-2. PubMed ID: 2298188
[TBL] [Abstract][Full Text] [Related]
35. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
Angst J; Woggon B
Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs.
Hansen LB; Elley J; Christensen TR; Larsen NE; Naestoft J; Hvidberg EF
Br J Clin Pharmacol; 1979 Jan; 7(1):75-80. PubMed ID: 760745
[TBL] [Abstract][Full Text] [Related]
38. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
39. The effect of neuroleptics on serum prolactin in schizophrenic patients.
Meltzer HY; Fang VS
Arch Gen Psychiatry; 1976 Mar; 33(3):279-86. PubMed ID: 1259521
[TBL] [Abstract][Full Text] [Related]
40. Effect of perphenazine on the secretion of prolactin in vivo and in vitro.
Blackwell R; Vale W; Rivier C; Guillemin R
Proc Soc Exp Biol Med; 1973 Jan; 142(1):68-71. PubMed ID: 4683266
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
